Ownership history in BVF INC/IL · 15 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 19,751,284 | — | 0% | 8.76% | $260.3M | $13.18 |
| 2025 Q3 | UNCHANGED | 19,751,284 | — | 0% | 5.74% | $141.6M | $7.17 |
| 2025 Q2 | UNCHANGED | 19,751,284 | — | 0% | 33.31% | $932.3M | $47.20 |
| 2025 Q1 | UNCHANGED | 19,751,284 | — | 0% | 31.45% | $771.7M | $39.07 |
| 2024 Q4 | REDUCED | 19,751,284 | -2,000,000 | -9.2% | 36.25% | $1.07B | $54.15 |
| 2024 Q3 | UNCHANGED | 21,751,284 | — | 0% | 32.08% | $1.10B | $50.42 |
| 2024 Q2 | UNCHANGED | 21,751,284 | — | 0% | 26.81% | $956.4M | $43.97 |
| 2024 Q1 | UNCHANGED | 21,751,284 | — | 0% | 30.04% | $1.09B | $50.23 |
| 2023 Q4 | UNCHANGED | 21,751,284 | — | 0% | 32.87% | $1.31B | $60.39 |
| 2023 Q3 | UNCHANGED | 21,751,284 | — | 0% | 33.43% | $1.24B | $57.00 |
As of 2025 Q4 — sorted by position size